Trial
NCT04249037
Rapid Start vs. Standard Start Antiretroviral Therapy (ART) in HIV
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Colorado, Denver
Collaborators
Gilead Sciences
Condition
HIV/AIDS
Intervention
bictegravir/emtricitabine/tenofovir alafenamide (BIC/F/TAF)
Why stopped
Insufficient enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-11-30